# Glycosylation Analysis of Lupus Anti-DNA Antibodies (GALA)

> **NCT05394922** · — · RECRUITING · sponsor: **University Hospital, Montpellier** · enrollment: 140 (estimated)

## Conditions studied

- Lupus Erythematosus Disseminatus
- Autoimmune Diseases
- Chronic Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05394922
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-08-23
- **Primary completion:** 2026-02-22
- **Final completion:** 2027-02-22
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2024-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05394922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05394922, "Glycosylation Analysis of Lupus Anti-DNA Antibodies (GALA)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05394922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*